Fund profile
Fund manager
Total assets
$43.00 mm
Liabilities
$692.27 k
Net assets
$42.30 mm
Number of holdings
148.00
148 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 1.12 mm | 3.12 k shares | 2.64 | Common equity | Long | USA |
INCY Incyte Corporation | 1.10 mm | 16.66 k shares | 2.60 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 1.10 mm | 16.15 k shares | 2.60 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 1.10 mm | 3.99 k shares | 2.59 | Common equity | Long | USA |
ABBV AbbVie Inc. | 1.08 mm | 5.45 k shares | 2.54 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 1.07 mm | 12.78 k shares | 2.53 | Common equity | Long | USA |
NTRA Natera, Inc. | 1.06 mm | 8.37 k shares | 2.51 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 1.06 mm | 8.49 k shares | 2.51 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.05 mm | 5.41 k shares | 2.48 | Common equity | Long | USA |
MRNA Moderna, Inc. | 1.04 mm | 15.50 k shares | 2.45 | Common equity | Long | USA |
INSM Insmed Incorporated | 1.04 mm | 14.18 k shares | 2.45 | Common equity | Long | USA |
AMGN Amgen Inc. | 1.03 mm | 3.18 k shares | 2.43 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 1.01 mm | 2.18 k shares | 2.40 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 1.00 mm | 15.86 k shares | 2.37 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 997.69 k | 8.66 k shares | 2.36 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 965.04 k | 918.00 shares | 2.28 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 876.45 k | 12.47 k shares | 2.07 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 706.73 k | 13.39 k shares | 1.67 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 676.73 k | 7.32 k shares | 1.60 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 664.21 k | 11.60 k shares | 1.57 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 628.83 k | 13.39 k shares | 1.49 | Common equity | Long | Switzerland |
Invesco Government & Agency Portfolio | 601.67 k | 601.67 k shares | 1.42 | Short-term investment vehicle | N/A | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 592.09 k | 2.79 k shares | 1.40 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 572.47 k | 12.46 k shares | 1.35 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 521.70 k | 2.87 k shares | 1.23 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 497.86 k | 21.29 k shares | 1.18 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 497.79 k | 12.43 k shares | 1.18 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 488.58 k | 24.44 k shares | 1.15 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 475.86 k | 10.49 k shares | 1.12 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 473.57 k | 41.04 k shares | 1.12 | Common equity | Long | Bermuda |
PCVX Vaxcyte, Inc. | 460.74 k | 4.03 k shares | 1.09 | Common equity | Long | USA |
ALKS Alkermes plc | 447.03 k | 15.97 k shares | 1.06 | Common equity | Long | Ireland |
BHVN Biohaven Ltd. | 429.69 k | 8.60 k shares | 1.02 | Common equity | Long | Virgin Islands (British) |
GERN Geron Corporation | 404.16 k | 89.02 k shares | 0.96 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 392.89 k | 8.70 k shares | 0.93 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 387.30 k | 15.21 k shares | 0.92 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 383.31 k | 40.82 k shares | 0.91 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 370.44 k | 10.31 k shares | 0.88 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 368.06 k | 12.76 k shares | 0.87 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 358.84 k | 13.83 k shares | 0.85 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 341.74 k | 6.15 k shares | 0.81 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 328.31 k | 15.98 k shares | 0.78 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 311.35 k | 6.09 k shares | 0.74 | Common equity | Long | USA |
NVAX Novavax, Inc. | 296.44 k | 23.47 k shares | 0.70 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 291.03 k | 3.49 k shares | 0.69 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 286.55 k | 11.70 k shares | 0.68 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 278.41 k | 42.25 k shares | 0.66 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 276.60 k | 8.63 k shares | 0.65 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 274.75 k | 17.86 k shares | 0.65 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 274.06 k | 2.68 k shares | 0.65 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 271.93 k | 25.46 k shares | 0.64 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 271.56 k | 9.53 k shares | 0.64 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 256.05 k | 37.16 k shares | 0.61 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 252.86 k | 5.62 k shares | 0.60 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 249.58 k | 7.88 k shares | 0.59 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 248.59 k | 5.60 k shares | 0.59 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 234.88 k | 6.33 k shares | 0.56 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 218.13 k | 4.94 k shares | 0.52 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 215.59 k | 11.13 k shares | 0.51 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 214.31 k | 7.36 k shares | 0.51 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 211.50 k | 4.04 k shares | 0.50 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 208.34 k | 5.34 k shares | 0.49 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 206.42 k | 10.72 k shares | 0.49 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 200.36 k | 3.41 k shares | 0.47 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 193.67 k | 4.09 k shares | 0.46 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 193.34 k | 5.69 k shares | 0.46 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 192.43 k | 5.65 k shares | 0.45 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 189.13 k | 6.91 k shares | 0.45 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 186.58 k | 4.11 k shares | 0.44 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 185.37 k | 4.91 k shares | 0.44 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 182.72 k | 16.40 k shares | 0.43 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 178.73 k | 3.54 k shares | 0.42 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 176.29 k | 23.20 k shares | 0.42 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 162.16 k | 5.65 k shares | 0.38 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 160.95 k | 17.31 k shares | 0.38 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 152.22 k | 7.66 k shares | 0.36 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 149.24 k | 2.57 k shares | 0.35 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 148.65 k | 8.05 k shares | 0.35 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 148.31 k | 6.77 k shares | 0.35 | Common equity | Long | USA |
VCEL Vericel Corporation | 141.88 k | 3.36 k shares | 0.34 | Common equity | Long | USA |
HSBC SECURITIES USA INC | 139.00 k | 139.00 k principal | 0.33 | Repurchase agreement | Long | USA |
CDNA CareDx, Inc | 133.21 k | 4.27 k shares | 0.31 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 131.47 k | 5.85 k shares | 0.31 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 129.79 k | 4.41 k shares | 0.31 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 128.92 k | 5.67 k shares | 0.30 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 127.16 k | 2.21 k shares | 0.30 | Common equity | Long | USA |
MNKD MannKind Corporation | 123.70 k | 19.67 k shares | 0.29 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 120.01 k | 7.17 k shares | 0.28 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 118.81 k | 8.53 k shares | 0.28 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 112.83 k | 2.30 k shares | 0.27 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 112.06 k | 5.74 k shares | 0.26 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 105.98 k | 28.49 k shares | 0.25 | Common equity | Long | USA |
SOCIETE GENERALE | 104.00 k | 104.00 k principal | 0.25 | Repurchase agreement | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 102.17 k | 24.80 k shares | 0.24 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 94.63 k | 4.08 k shares | 0.22 | Common equity | Long | USA |
APLT Applied Therapeutics, Inc. | 84.63 k | 9.96 k shares | 0.20 | Common equity | Long | USA |
CATX Perspective Therapeutics, Inc. | 84.41 k | 6.32 k shares | 0.20 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 84.40 k | 20.29 k shares | 0.20 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 84.00 k | 15.44 k shares | 0.20 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 81.42 k | 7.16 k shares | 0.19 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 81.41 k | 10.87 k shares | 0.19 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 81.04 k | 2.42 k shares | 0.19 | Common equity | Long | USA |
XNCR Xencor, Inc. | 80.80 k | 4.02 k shares | 0.19 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 80.49 k | 5.26 k shares | 0.19 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 80.26 k | 5.74 k shares | 0.19 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 79.69 k | 11.26 k shares | 0.19 | Common equity | Long | USA |
IMNM Immunome, Inc. | 79.59 k | 5.44 k shares | 0.19 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 76.76 k | 7.11 k shares | 0.18 | Common equity | Long | USA |
EBS Emergent BioSolutions Inc. | 75.18 k | 9.00 k shares | 0.18 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 73.67 k | 5.08 k shares | 0.17 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 69.34 k | 6.33 k shares | 0.16 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 67.53 k | 5.66 k shares | 0.16 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 67.30 k | 9.32 k shares | 0.16 | Common equity | Long | USA |
ANNX Annexon, Inc. | 65.45 k | 11.06 k shares | 0.15 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 65.10 k | 3.89 k shares | 0.15 | Common equity | Long | Ireland |
VERV Verve Therapeutics, Inc. | 63.83 k | 13.19 k shares | 0.15 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 63.60 k | 5.18 k shares | 0.15 | Common equity | Long | USA |
CREDIT AGRICOLE CIB NY | 62.00 k | 62.00 k principal | 0.15 | Repurchase agreement | Long | USA |
Natwest Markets PLC | 62.00 k | 62.00 k principal | 0.15 | Repurchase agreement | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 61.05 k | 5.65 k shares | 0.14 | Common equity | Long | USA |
ALT Altimmune, Inc. | 59.80 k | 9.74 k shares | 0.14 | Common equity | Long | USA |
ETNB 89bio, Inc. | 58.93 k | 7.96 k shares | 0.14 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 57.93 k | 7.23 k shares | 0.14 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 55.48 k | 19.81 k shares | 0.13 | Common equity | Long | USA |
CELC Celcuity Inc. | 52.75 k | 3.54 k shares | 0.12 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 52.46 k | 1.92 k shares | 0.12 | Common equity | Long | USA |
CCCC C4 Therapeutics, Inc. | 51.26 k | 8.99 k shares | 0.12 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 50.26 k | 4.79 k shares | 0.12 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 49.57 k | 8.73 k shares | 0.12 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 49.56 k | 6.44 k shares | 0.12 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 49.46 k | 49.85 k shares | 0.12 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 46.92 k | 13.41 k shares | 0.11 | Common equity | Long | USA |
UMB FINANCIAL CORP | 46.00 k | 46.00 k principal | 0.11 | Repurchase agreement | Long | USA |
ROYAL BANK OF CANADA | 46.00 k | 46.00 k principal | 0.11 | Repurchase agreement | Long | USA |
SVRA Savara Inc. | 44.57 k | 10.51 k shares | 0.11 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 43.90 k | 2.13 k shares | 0.10 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 41.38 k | 4.04 k shares | 0.10 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 41.09 k | 6.95 k shares | 0.10 | Common equity | Long | USA |
ERAS Erasca, Inc. | 39.62 k | 14.51 k shares | 0.09 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 36.74 k | 3.34 k shares | 0.09 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 31.90 k | 1.73 k shares | 0.08 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 31.81 k | 3.12 k shares | 0.08 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals, Inc. | 31.73 k | 2.74 k shares | 0.08 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 28.84 k | 2.19 k shares | 0.07 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 27.69 k | 7.19 k shares | 0.07 | Common equity | Long | Canada |
ALEC Alector, Inc. | 21.19 k | 4.55 k shares | 0.05 | Common equity | Long | USA |
AVBP ArriVent BioPharma, Inc. Common Stock | 14.01 k | 596.00 shares | 0.03 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
GOLDMAN SACHS GROUP, INC
|
-2.67 k | 65.00 other units | -0.01 | Equity derivative | N/A | USA |